EVITRADE Health Systems Announces Closing Details of Financing at $2.25 Million

Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) is pleased to announce that it has closed the financing at $2,250,000 by way of a non-brokered private placement for 15,000,000 Units (“Units”) of the Company at a price of CAD $0.15 per Unit (the “Offering”). Each Unit is one Common Share in the capital of the Company and one Whole Common Share Purchase Warrant.  Each Warrant is exercisable into one Common Share at a price of CAD $0.25 per Common Share for sixty (60) months from the closing date of the Offering.

In connection with the Offering, the Company will pay cash finder's fees of up to seven percent (7%) of the principal amount of funds raised by the two brokerage houses who participated in the Offering.  Insiders also participated in the financing.

Net Proceeds from the Offering are intended to be used as working capital, and for general corporate purposes. The Securities to be issued in connection with this Offering will be subject to a four month and one day hold period from the share issuance date in accordance with the policies of the Canadian Securities Exchange (CSE) and applicable securities laws. The Offering is subject to all necessary regulatory and stock exchange approvals.

Contact:

Ron Ozols, Director

EVITRADE Health Systems Corporation

(formerly Auxellence Health Corporation)

Email: ceo@auxellence.com or info@auxellence.com

Website: http://www.auxellence.com

CSE Micro-site: http://thecse.com/en/listings/technology/auxellence-health-corporation

About EVITRADE Health Systems Corporation (CSE: EVA, OTCQB: AXHLF)

EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online services for resolving common health problems.

Disclaimers – Forward Looking Statements

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators which is posted on www.sedar.com, and on http://thecse.com/en/listings/technology/auxellence-health-corporation.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the icons below.

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright © 2017 FSCwire